30 Sept 2026RPG Life Sciences Ltd newspaper advertisement for special window for transfer and dematerialisation of physical securitiesCapital Raise
26 Sept 2026RPG Life Sciences Ltd subsidiary RPG Active Pharma approves scheme of amalgamation of Actis Generics Private Limited with itselfRestructuring
24 Sept 2026RPG Life Sciences Ltd announces completion of acquisition of Actis Generics Private Limited by subsidiary RPG Active Pharma on 24 Sep 2026Restructuring
15 Sept 2026RPG Life Sciences Ltd completion of slump sale of APIs and intermediates business to Raghava Life Sciences effective September 16, 2026Restructuring
9 Sept 2026RPG Life Sciences Ltd intimation of allotment of 40% equity in subsidiary RPGAP to ILSF and VJF for INR 243.33 crores on 09 Sep 2026Restructuring
2 Sept 2026RPG Life Sciences Ltd board approves acquisition of API and intermediates business from Raghava Life Sciences via slump sale on 02 Sep 2026Restructuring
2 Sept 2026RPG Life Sciences Ltd announces acquisition of API business of Raghava Life Sciences for up to ₹135 croreRestructuring
22 Jun 2026RPG Life Sciences Ltd fixes record date July 9, 2026 for final dividend of Rs 24 per shareRecord Date
9 Jun 2026RPG Life Sciences Limited dividend tax deduction communication for FY26 under Regulation 30 scheduled on June 09, 2026Record Date
15 May 2026RPG Life Sciences Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A filed on May 15, 2026Audit Reports
